Skip to main content
Figure 2 | Molecular Cancer

Figure 2

From: Promoter methylation of IGFBP-3 and p53 expression in ovarian endometrioid carcinoma

Figure 2

Kaplan Meier survival estimate of progression-free survival (PFS) and overall survival (OS) for OEC patients classified by (a) IGFBP-3 expression, (b) IGFBP-3 promoter methylation status and (c) p53 expression. (d) Survival estimate for patients with normal p53, classified according to IGFBP-3 expressions and IGFBP-3 promoter methylation status. --- indicates patients with high IGFBP-3 and IGFBP-3 promoter methylation ≤ 3%; --- indicates patients with unparallel IGFBP-3 and IGFBP-3 promoter methylation, i.e. either high IGFBP-3 and IGFBP-3 promoter methylation >; 3% or low IGFBP-3 and IGFBP-3 promoter methylation ≤ 3%; --·-indicates patients with low IGFBP-3 and IGFBP-3 promoter methylation > 3%. Logrank test was used to compare survival distributions.

Back to article page